Activist Saba Capital Intensifies Proxy Fight, Urges Shareholders to Elect Independent Trustee
Summary
Activist investor Saba Capital Management, holding 5.9% of shares, filed definitive additional proxy materials, detailing its case for electing an independent trustee to The Gabelli Dividend & Income Trust's board due to alleged underperformance and governance issues.
Key Events
-
Proxy Battle Escalates
Saba Capital, a 5.9% shareholder, released definitive proxy materials detailing its case against the current board, following previous filings on April 6th and April 13th.
-
Allegations of Underperformance
Saba claims GDV has underperformed peers and benchmarks over the past decade in share price, NAV return, and trading discount.
-
Governance Concerns Raised
The filing criticizes the board's lack of independence, high expense ratio, high voting thresholds for nominees, preferred shareholder influence, and staggered board terms.
-
Independent Nominee Proposed
Saba is soliciting votes for its independent candidate, Andre Clemot, to join the 13-member Board of Trustees.
Analysis
This filing represents a critical escalation in the ongoing proxy contest initiated by Saba Capital. It provides shareholders with Saba's comprehensive arguments, alleging long-term underperformance, excessive fees, and a lack of independence and accountability within the current 13-member Board of Trustees. Saba highlights specific governance concerns, including a high voting threshold for dissident nominees, the influence of preferred shareholders, staggered board terms, and over-tenured, "overboarded" trustees with minimal share ownership. The filing directly solicits votes for Saba's independent nominee, Andre Clemot, aiming to bring a fresh perspective and improve shareholder alignment. Investors should carefully review these arguments as the outcome of this proxy fight could significantly impact the fund's future governance and strategy.
At the time of this filing, GDV was trading at $29.26 on NYSE in the Unknown sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $21.82 to $29.46. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.